MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Mon May 14 00:00:00 GMT-05:00 2018
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
Download
Tue May 08 00:00:00 GMT-05:00 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)
Download
Wed Apr 04 00:00:00 GMT-05:00 2018
Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative
Download
Tue Mar 27 00:00:00 GMT-05:00 2018
Daiichi Sankyo, Inc. and the Crohn’s & Colitis Foundation Launch Get Iron Informed
Download
Tue Mar 27 00:00:00 GMT-05:00 2018
Daiichi Sankyo's HER2-Targeting Antibody Drug Conjugate DS-8201 Receives SAKIGAKE Designation for Gastric Cancer from Japan MHLW
Download
Wed Mar 07 00:00:00 GMT-05:00 2018
Daiichi Sankyo Initiates Phase 2 Study of DS-8201 in Patients with HER2-Expressing Advanced Colorectal Cancer
Download
Wed Feb 28 00:00:00 GMT-05:00 2018
Daiichi Sankyo, Inc. Aligns U.S. Commercial Operations to Current Portfolio and Upcoming Cancer Pipeline
Download
Thu Feb 22 00:00:00 GMT-05:00 2018
Daiichi Sankyo Initiates Phase 1 Study of DS-1062 in Patients with Advanced Non-Small Cell Lung Cancer
Download
Tue Feb 06 00:00:00 GMT-05:00 2018
Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Download